table of content
1 Introduction to Research & Analysis Reports
1.1 Oncology Targeted Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oncology Targeted Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oncology Targeted Therapy Overall Market Size
2.1 Global Oncology Targeted Therapy Market Size: 2022 VS 2029
2.2 Global Oncology Targeted Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Oncology Targeted Therapy Players in Global Market
3.2 Top Global Oncology Targeted Therapy Companies Ranked by Revenue
3.3 Global Oncology Targeted Therapy Revenue by Companies
3.4 Top 3 and Top 5 Oncology Targeted Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Oncology Targeted Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oncology Targeted Therapy Players in Global Market
3.6.1 List of Global Tier 1 Oncology Targeted Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Oncology Targeted Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Oncology Targeted Therapy Market Size Markets, 2022 & 2029
4.1.2 Sorafenib
4.1.3 Lenvatinib
4.1.4 Regorafenib
4.1.5 Osimertinib
4.1.6 Anlotinib
4.1.7 Alectinib
4.1.8 Other
4.2 By Type - Global Oncology Targeted Therapy Revenue & Forecasts
4.2.1 By Type - Global Oncology Targeted Therapy Revenue, 2018-2023
4.2.2 By Type - Global Oncology Targeted Therapy Revenue, 2024-2029
4.2.3 By Type - Global Oncology Targeted Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Oncology Targeted Therapy Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 By Application - Global Oncology Targeted Therapy Revenue & Forecasts
5.2.1 By Application - Global Oncology Targeted Therapy Revenue, 2018-2023
5.2.2 By Application - Global Oncology Targeted Therapy Revenue, 2024-2029
5.2.3 By Application - Global Oncology Targeted Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Oncology Targeted Therapy Market Size, 2022 & 2029
6.2 By Region - Global Oncology Targeted Therapy Revenue & Forecasts
6.2.1 By Region - Global Oncology Targeted Therapy Revenue, 2018-2023
6.2.2 By Region - Global Oncology Targeted Therapy Revenue, 2024-2029
6.2.3 By Region - Global Oncology Targeted Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Oncology Targeted Therapy Revenue, 2018-2029
6.3.2 US Oncology Targeted Therapy Market Size, 2018-2029
6.3.3 Canada Oncology Targeted Therapy Market Size, 2018-2029
6.3.4 Mexico Oncology Targeted Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Oncology Targeted Therapy Revenue, 2018-2029
6.4.2 Germany Oncology Targeted Therapy Market Size, 2018-2029
6.4.3 France Oncology Targeted Therapy Market Size, 2018-2029
6.4.4 U.K. Oncology Targeted Therapy Market Size, 2018-2029
6.4.5 Italy Oncology Targeted Therapy Market Size, 2018-2029
6.4.6 Russia Oncology Targeted Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Oncology Targeted Therapy Market Size, 2018-2029
6.4.8 Benelux Oncology Targeted Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Oncology Targeted Therapy Revenue, 2018-2029
6.5.2 China Oncology Targeted Therapy Market Size, 2018-2029
6.5.3 Japan Oncology Targeted Therapy Market Size, 2018-2029
6.5.4 South Korea Oncology Targeted Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Oncology Targeted Therapy Market Size, 2018-2029
6.5.6 India Oncology Targeted Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Oncology Targeted Therapy Revenue, 2018-2029
6.6.2 Brazil Oncology Targeted Therapy Market Size, 2018-2029
6.6.3 Argentina Oncology Targeted Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Oncology Targeted Therapy Revenue, 2018-2029
6.7.2 Turkey Oncology Targeted Therapy Market Size, 2018-2029
6.7.3 Israel Oncology Targeted Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Oncology Targeted Therapy Market Size, 2018-2029
6.7.5 UAE Oncology Targeted Therapy Market Size, 2018-2029
7 Oncology Targeted Therapy Companies Profiles
7.1 Bayer
7.1.1 Bayer Company Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Oncology Targeted Therapy Major Product Offerings
7.1.4 Bayer Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.1.5 Bayer Key News & Latest Developments
7.2 Eisai
7.2.1 Eisai Company Summary
7.2.2 Eisai Business Overview
7.2.3 Eisai Oncology Targeted Therapy Major Product Offerings
7.2.4 Eisai Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.2.5 Eisai Key News & Latest Developments
7.3 Zelgen
7.3.1 Zelgen Company Summary
7.3.2 Zelgen Business Overview
7.3.3 Zelgen Oncology Targeted Therapy Major Product Offerings
7.3.4 Zelgen Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.3.5 Zelgen Key News & Latest Developments
7.4 Cipla
7.4.1 Cipla Company Summary
7.4.2 Cipla Business Overview
7.4.3 Cipla Oncology Targeted Therapy Major Product Offerings
7.4.4 Cipla Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.4.5 Cipla Key News & Latest Developments
7.5 Natco Pharma
7.5.1 Natco Pharma Company Summary
7.5.2 Natco Pharma Business Overview
7.5.3 Natco Pharma Oncology Targeted Therapy Major Product Offerings
7.5.4 Natco Pharma Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.5.5 Natco Pharma Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Oncology Targeted Therapy Major Product Offerings
7.6.4 AstraZeneca Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 Novartis
7.7.1 Novartis Company Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Oncology Targeted Therapy Major Product Offerings
7.7.4 Novartis Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.7.5 Novartis Key News & Latest Developments
7.8 Roche
7.8.1 Roche Company Summary
7.8.2 Roche Business Overview
7.8.3 Roche Oncology Targeted Therapy Major Product Offerings
7.8.4 Roche Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.8.5 Roche Key News & Latest Developments
7.9 Bristol-Myers Squibb
7.9.1 Bristol-Myers Squibb Company Summary
7.9.2 Bristol-Myers Squibb Business Overview
7.9.3 Bristol-Myers Squibb Oncology Targeted Therapy Major Product Offerings
7.9.4 Bristol-Myers Squibb Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.9.5 Bristol-Myers Squibb Key News & Latest Developments
7.10 Pfizer
7.10.1 Pfizer Company Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Oncology Targeted Therapy Major Product Offerings
7.10.4 Pfizer Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.10.5 Pfizer Key News & Latest Developments
7.11 BEACON Pharma
7.11.1 BEACON Pharma Company Summary
7.11.2 BEACON Pharma Business Overview
7.11.3 BEACON Pharma Oncology Targeted Therapy Major Product Offerings
7.11.4 BEACON Pharma Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.11.5 BEACON Pharma Key News & Latest Developments
7.12 Jiangxi Shanxiang
7.12.1 Jiangxi Shanxiang Company Summary
7.12.2 Jiangxi Shanxiang Business Overview
7.12.3 Jiangxi Shanxiang Oncology Targeted Therapy Major Product Offerings
7.12.4 Jiangxi Shanxiang Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.12.5 Jiangxi Shanxiang Key News & Latest Developments
7.13 Yao Pharma
7.13.1 Yao Pharma Company Summary
7.13.2 Yao Pharma Business Overview
7.13.3 Yao Pharma Oncology Targeted Therapy Major Product Offerings
7.13.4 Yao Pharma Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.13.5 Yao Pharma Key News & Latest Developments
7.14 CSPC
7.14.1 CSPC Company Summary
7.14.2 CSPC Business Overview
7.14.3 CSPC Oncology Targeted Therapy Major Product Offerings
7.14.4 CSPC Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.14.5 CSPC Key News & Latest Developments
7.15 CHIATAI Tianqing
7.15.1 CHIATAI Tianqing Company Summary
7.15.2 CHIATAI Tianqing Business Overview
7.15.3 CHIATAI Tianqing Oncology Targeted Therapy Major Product Offerings
7.15.4 CHIATAI Tianqing Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.15.5 CHIATAI Tianqing Key News & Latest Developments
7.16 Simcere
7.16.1 Simcere Company Summary
7.16.2 Simcere Business Overview
7.16.3 Simcere Oncology Targeted Therapy Major Product Offerings
7.16.4 Simcere Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.16.5 Simcere Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
